Ying Luo
Direktor/Vorstandsmitglied bei Bellen Chemistry Co., Ltd.
Profil
Ying Luo is currently working as a Director at Shanghai Haihe Biopharma Co., Ltd., as well as at NKD Pharma Co., Ltd.
and as a Member-Supervisory Board at Bellen Chemistry Co., Ltd.
Previously, Ms. Luo worked as a Member-Supervisory Board at Shanghai MicuRx Pharmaceutical Co., Ltd.
Ms. Luo holds an MBA degree from Northwestern University, which was conferred in 2001.
Aktive Positionen von Ying Luo
Unternehmen | Position | Beginn |
---|---|---|
Bellen Chemistry Co., Ltd.
Bellen Chemistry Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Bellen Chemistry Co., Ltd. provides contract chemistry services. It offers chemical synthesis contract development and manufacturing organization (CDMO) services, chemical synthesis contract research organization (CRO) services, and drug molecular building blocks. The company was founded by Bo Liu, Li Xin Xing, Jian Hua Ren, Jian Xun Liu, and Yong Jun Jiang on January 28, 2010 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 01.10.2020 |
NKD Pharma Co., Ltd.
NKD Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology NKD Pharma Co., Ltd. engages in the provision of entrusted research and development services, and independent project research and development services. Its entrusted research and development services cover pharmaceutical research, non-clinical research, and clinical research services for pharmaceutical companies and pharmaceutical research and development investment companies. Its independent project research and development services encompass generic drug, medical devices, and special medical food development services. The company was founded by Peng Chen, Xiu Mei Tao, Chun Peng Wang, and Ke Min Li on July 23, 2013 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 01.09.2019 |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | 12.06.2020 |
Ehemalige bekannte Positionen von Ying Luo
Unternehmen | Position | Ende |
---|---|---|
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | - |
Ausbildung von Ying Luo
Northwestern University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
Health Technology |
Private Unternehmen | 3 |
---|---|
Bellen Chemistry Co., Ltd.
Bellen Chemistry Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Bellen Chemistry Co., Ltd. provides contract chemistry services. It offers chemical synthesis contract development and manufacturing organization (CDMO) services, chemical synthesis contract research organization (CRO) services, and drug molecular building blocks. The company was founded by Bo Liu, Li Xin Xing, Jian Hua Ren, Jian Xun Liu, and Yong Jun Jiang on January 28, 2010 and is headquartered in Beijing, China. | Commercial Services |
NKD Pharma Co., Ltd.
NKD Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology NKD Pharma Co., Ltd. engages in the provision of entrusted research and development services, and independent project research and development services. Its entrusted research and development services cover pharmaceutical research, non-clinical research, and clinical research services for pharmaceutical companies and pharmaceutical research and development investment companies. Its independent project research and development services encompass generic drug, medical devices, and special medical food development services. The company was founded by Peng Chen, Xiu Mei Tao, Chun Peng Wang, and Ke Min Li on July 23, 2013 and is headquartered in Beijing, China. | Health Technology |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |